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576 The Journal of Thoracic and CardioObjectives: The mechanisms of postoperative cognitive dysfunction in patients with
diabetes after coronary artery bypass grafting are not fully understood. We sought
to determine which type 2 diabetes–related factors contributed to postoperative
cognitive dysfunction at 7 days and 6 months after coronary artery bypass grafting.
Methods: One hundred eighty patients with type 2 diabetes who were scheduled for
elective coronary artery bypass grafting were studied. As a control group, 100
patients without diabetes mellitus matched for age, sex, and educational level were
examined. Hemodynamic parameters (arterial and jugular venous blood gas values)
were measured during cardiopulmonary bypass. All patients underwent a battery of
neurologic and neuropsychologic tests the day before surgery, 7 days after surgery,
and 6 months after surgery.
Results: Age (odds ratio 1.5, 95% confidence interval 1.3-1.8, P .03), presence of
hypertension (odds ratio 1.8, 95% confidence interval 1.3-2.0, P  .01), jugular
venous oxygen saturation less than 50% time (odds ratio 1.5, 95% confidence
interval 1.1-2.0, P  .045), presence of ascending aorta atherosclerosis (odds ratio
1.5, 95% confidence interval 1.1-2.6, P  .01), diabetic retinopathy (odds ratio 2.0,
95% confidence interval 1.3-3.0, P  .01), and insulin therapy (odds ratio 2.0, 95%
confidence interval 1.3-3.0, P  .05), were associated with cognitive impairment at
7 days. Insulin therapy (odds ratio 2.0, 95% confidence interval 1.3-3.8, P  .01),
diabetic retinopathy (odds ratio 1.3, 95% confidence interval 1.2-2.9, P  .01), and
hemoglobin A1c (odds ratio 1.9, 95% confidence interval 1.3-3.1, P  .047) were
associated with cognitive impairment at 6 postoperative months.
Conclusions: Insulin therapy, diabetic retinopathy, and hemoglobin A1c were factors
in cognitive impairment at 7 days and 6 months after coronary artery bypass grafting
in patients with type 2 diabetes.
Extant diabetes mellitus is a key factor associated with adverse post-operative neurologic outcomes after coronary artery bypass grafting(CABG).1 Thourani and colleagues2 reported that perioperative neu-rologic complications were more frequent among patients with dia-betes than among patients without diabetes. However, the mecha-nisms of postoperative cognitive dysfunction in patients with
diabetes after CABG are not fully understood.1
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PGarcia and associates3 reported a higher mortality for
women with insulin-treated diabetes than for patients with
orally treated diabetes. Lawrie and colleagues4 noted that
preoperative blood glucose level was an important predictor
of late mortality among patients with diabetes. These find-
ings suggest that the need for insulin treatment is one of the
predictors of postoperative cognitive dysfunction in patients
with diabetes. In contrast, Thourani and colleagues2 re-
ported that although perioperative neurologic complications
were more frequent in patients with diabetes than in patients
without diabetes, there was no difference in the incidence of
perioperative neurologic complications between patients
with type 1 and type 2 diabetes. Previously, there have been
no reports examining the question of what diabetes-related
factors other than the need for insulin treatment contribute
to cognitive dysfunction after CABG in patients with type 2
diabetes.
Patients and Methods
This study was approved by the ethics committee of our institution,
and written, informed consent was obtained from all patients.
Between May 1994 and May 2000, a total of 199 patients with
diabetes scheduled for elective CABG were approached, and 196
patients agreed to participate in this study. There was little change
in anesthetic, surgical, and perfusion techniques during this period.
Patients with type 2 diabetes mellitus were defined as those whose
medical records showed a diagnosis of type 2 diabetes and medical
treatment with antidiabetic therapy, such as dietary, oral, or insulin
therapy. Duration of disease was defined as the duration from the
time at which medical treatment was started. Some patients were
the same as in other publications from our group.5,6 Patients with
type 1 diabetes were excluded because their pathophysiology was
quite different from that of patients with type 2 diabetes. We also
studied 100 control patients without diabetes mellitus matched for
age, weight, height, sex, and educational level. Table 1 shows the
demographic data of the two groups.
Patients with a history of stroke or psychiatric illness were
excluded. To rule out the possibility of the influence of renal
failure or hepatic dysfunction on neurologic and neuropsychologic
tests, we also excluded patients with renal disease (creatinine
concentration 2.0 mg/dL) or active liver disease (glutamine
oxaloacetate transaminase or glutamine pyruvate transaminase
50 U/dL). All enrolled patients had undergone ophthalmologic
examination for detection of diabetic retinopathy. Because glyco-
sylated hemoglobin (HbA1c, normal value, 4.5%-5.8%) is one of
the indicators of diabetes control, all patients with diabetes were
examined for preoperative HbA1c level.
Anesthetic management was similar to that described in our
previous study.5-7 Hemodynamic parameters and arterial and jug-
ular venous blood gas values were measured at different times as
described previously elsewhere.5-7
The target tympanic temperatures were from 34.5°C to 36.0°C.
Below 34.5°C, a 34°C to 4°C difference between tympanic tem-
perature and cardiopulmonary bypass (CPB) perfusate temperature
was maintained during rewarming. The limit on maximal inflow
temperature was set at 37.5°C. Phenylephrine infusions were used
during CPB to maintain mean arterial pressure of 50 to 80 mm Hg.
The Journal of ThoraciBlood glucose level during CPB was maintained between 100 and
200 mg/dL with insulin infusions. Pericardial aspirate was returned
to the bypass circuit. Distal coronary anastomoses and proximal
anastomoses were performed during a single aortic crossclamping.
Data analysis was later performed by an individual blinded to
the groups to which patients belonged. The presence or absence of
carotid artery stenosis in patients with or without diabetes was
confirmed by preoperative ultrasonography and magnetic reso-
nance imaging or angiography. The lesions found on ultrasonog-
raphy and magnetic resonance imaging or magnetic resonance
angiography were independently evaluated by two or three trained
specialists who were blinded to preoperative risk factors and
symptoms. The presence of carotid artery stenosis was defined as
narrowing greater than 50%8 We evaluated the presence of ath-
erosclerotic lesions in the ascending aorta with intraoperative
epiaortic ultrasonography during surgery in both diabetes and
control groups. The presence of atherosclerotic lesions in the
ascending aorta was defined as atherosclerotic lesions with at least
3.0 mm thickening with diffuse irregularities, large mobile or
protruding atheromata, ulcerated plaques, or thrombi.8 To deter-
mine diabetic retinopathy status at the preoperative period, all
fundus photographs were examined for the presence of diabetic
retinopathy according to a modification of the Diabetic Retinopa-
thy Study and the Early Treatment Diabetic Retinopathy Study
grading scale.9 The presence of atherosclerotic lesions or diabetic
retinopathy was determined by trained specialists, with intraob-
server and interobserver validity ensured. Those who examined
these lesions were unaware of each patient’s intraoperative treat-
TABLE 1. Demographic data from patients with type 2
diabetes and control patients
Diabetes Control
No. 180 100
Age (y, mean  SD) 64 11 67  8
Height (cm, mean  SD) 161 11 164  11
Weight (kg, mean  SD) 64 11 62  10
Left ventricular ejection fraction (%,
mean  SD)
58  9 59  8
Hypertension (No.) 136 (76%) 70 (70%)
-Blocker (No.) 36 21
Angiotensin-converting, enzyme blocker
(No.)
46 29
Calcium channel antagonist (No.) 52 20
Smoking (No.) 91 (51%) 50 (50%)
Male/female ratio 140:40 70:30
Peak perioperative glucose level (mg/dL,
mean  SD)
211 41 220  50
HbA1c (%, mean  SD) 6.8  3.6* 4.5  0.8
Educational level (y, mean  SD) 11.8 2.2 12.3  2.0
Preoperative hemoglobin (g/dL,
mean  SD)
12.5 1.5 12.8  1.9
Total CPB time (min, mean  SD) 111 31 119  29
Aortic clamping time (min, mean  SD) 99 34 108  22
*P .05 versus control; unpaired t test or 2 test was used for comparison
between groups.ment assignment. Both examinations were performed for all pa-
c and Cardiovascular Surgery ● Volume 129, Number 3 577
Cardiopulmonary Support and Physiology Kadoi et al
CSPtients. We defined integrated area under mean arterial pressure
curve, change in tympanic temperature, and jugular venous oxygen
saturation (SvO2) less than 50% time as follows: integrated area
under the curve for mean arterial pressure less than 50 mm Hg,
tympanic temperature at the start of CPB minus tympanic temper-
ature 20 minutes after the start of CPB, and time at which SvO2
was less than 50%.
Neurologic and Neuropsychologic Assessments
All patients underwent a battery of neurologic and neuropsycho-
logic tests administered by trained specialists, with intraobserver
and interobserver validity ensured, the day before the operation
and 7 days and 6 months after the surgery. The examiners who
administered the cognitive tests were unaware of whether patients
were in the control or diabetes group. Postoperative new stroke
was defined according to both clinical assessment and either brain
computed tomography or magnetic resonance imaging by trained
specialists. The neuropsychologic portion of the study was de-
signed in accordance with the consensus statements on the assess-
ment of central nervous system disorders after cardiac surgery.10
Cognitive functioning was assessed with the following tests: (1)
Mini-Mental State Examination, (2) Rey Auditory Verbal Learn-
ing Test, (3) Trail-Making Test (part A), (4) Trail-Making Test
(part B), (5) Digit Span Forward, and (6) Grooved Pegboard.
Statistical Analysis
All data are expressed as mean  SD. After the study was
completed, sample size was evaluated. On the basis of our previ-
ous study, we considered a 20% reduction in cognitive dysfunction
to be clinically important. The sample size provided 80% power to
detect a 20% difference between patients with diabetes with insu-
lin therapy and patients with diabetes without insulin therapy with
a 5% probability of type I error. To obtain an indicator of outcome
overall, significant impairment was defined as a decline from
preoperative testing of more than 1 SD on more than 20% of test
measures (at least 2 of 6). Differences in neuropsychologic tests
between preoperative values and values obtained 7 days and 6
months after the operation were assessed with an analysis of
covariance between diabetic and control groups. The data were
examined with the Bartlett test to determine whether the variance
was normally distributed between the groups. Univariate compar-
isons between subjects with and without cognitive impairment
were performed with unpaired t test or 2 test for dichotomous
variables and analysis of variance for ordered categoric and con-
tinuous variables. The latter analyses were performed nonpara-
metrically when regression residuals suggested that the model fit
was poor. Stepwise logistic regression was used to choose a best
set of independent predictors of both short- and long-term cogni-
tive impairment. Variables entered into the initial logistic models
were those with a univariate probability value of P  .2. The final
model included all variables with an independent significance level
of P  .1. The quality of the fit of the logistic model was tested
with the Hosmer-Lemeshow goodness-of-fit test. All calculations
were performed on a Macintosh computer (Apple Computer, Inc,
Cupertino, Calif) with SPSS (SPSS, Inc, Chicago, Ill) and Stat-
View 5.0 (SAS Institute, Inc, Cary, NC) software packages.
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Table 1 shows the demographic data from the diabetes
and control groups. There were no significant differences
in demographic data between the two groups. The epi-
aortic scanning showed that 53 patients with diabetes had
ascending aorta atherosclerosis and 12 control patients
had ascending aorta atherosclerosis (P  .05).
We were unable to perform neuropsychologic assess-
ments for 7 patients with diabetes (5 in insulin group and
2 in noninsulin group 2) 6 months after the operation,
because these patients had died within 6 months after the
surgery (mortality in insulin group 6% [5/83], mortality
in noninsulin group 2% [2/104], P  .05). Three patients
(excluding patients with major neurologic defects) had
incomplete cognitive data, and 4 patients refused follow-
up.
Major neurologic defects (defined as clinical evidence of
focal cerebral infarction including hemiparesis, visual or
gait disturbance, mental changes [confusion, agitation, in-
ability to make contact with other people], or a combination
of these) were observed in 9 patients after the operation
(patients with diabetes with insulin therapy 5/86 [5.8%],
patients with diabetes without insulin therapy 4/103 [3.9%],
control group 1/100 [1.0%], P  .19).
We then performed neuropsychologic assessments for
the 180 patients with diabetes. There was a significant
difference in the incidence of cognitive impairment at 7
days between the control group and patients with diabetes
(control 55/99 [55%], patients with diabetes 122/180 [68%],
P  .04). In addition, there was a significant difference in
the incidence of cognitive impairment at 6 months between
the control group and patients with diabetes (control 11/99
[11%], patients with diabetes 51/180 [28%], P  .0006).
Table 2 shows raw neurocognitive test scores at baseline
and at 7 days and 6 months after the operation. Among
patients with diabetes with cognitive impairment at 6
months, incidence of cognitive decline did not differ signif-
icantly between female and male patients (male 37/140
[26.4%], female 14/40 [35%], P  .30).
To assess whether elevated blood glucose level is a risk
factor for cognitive impairment among patients with diabe-
tes or whether patients with diabetes in general are at
increased risk, we analyzed risk factors related to cognitive
impairment at 7 days and 6 months in all patients. We found
that age (odds ratio [OR] 1.4, 95% confidence interval [CI]
1.0-1.5), SvO2 less than 50% time (OR 1.2, 95% CI 1.0-1.3),
CPB time (OR 1.1, 95% CI 1.0-1.2), hypertension (OR 1.7,
95% CI 1.0-1.9), ascending aorta atherosclerosis (OR 1.6,
95% CI 1.0-1.8), and diabetes (OR 2.2, 95% CI 1.6.-3.3)
were associated with cognitive impairment at 7 days. Dia-
betes (OR 2.5, 95% CI 1.4.-3.6) was associated with cog-
nitive impairment at 6 months. No relationship was found
between a weighted average of blood glucose levels for
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Peach 24-hour period and postoperative cognitive impair-
ment at 7 days or 6 months in either the control or the
diabetic group. At 7 days, there was no significant differ-
ence in incidence of cognitive decline, HbA1c, or fasting
blood sugar between patients with diabetes with insulin
therapy and patients with diabetes without insulin therapy
(Table 3). Incidence of diabetic retinopathy differed signif-
TABLE 2. Raw neurocognitive test scores at baseline and
Test Baseline
Mini-Mental State Examination
Diabetes 45.5 2.9
Control 46.3 2.5
Trail-Making Test (part A)
Diabetes 45.9 6.1
Control 45.4 6.5
Trail-Making Test (part B)
Diabetes 159.5 22.
Control 163.5 23.
Digit Span Forward
Diabetes 9.3 2.6
Control 9.4 2.2
Grooved Pegboard
Diabetes 22.3 3.2
Control 21.9 3.0
Immediate recall
Diabetes 40.7 6.5
Control 39.9 4.2
Delayed recall
Diabetes 23.4 4.1
Control 22.4 3.9
Values are mean  SD. The immediate and delayed recall scores are de
*P  .05 versus baseline.
†P  .05 versus control.
TABLE 3. Analysis of patients with type 2 diabetes and co
after operation and at 6 months after operation
Wi
7 d (n  122)
No. 54
Fasting blood sugar (mg/dL, mean  SD) 1
HbA1c (%, mean  SD) 6
Diabetic retinopathy (No.) 40/
Duration of disease (y, mean  SD) 8
6 mo (n  .51)
No. 41/
Fasting blood sugar (mg/dL, mean  SD) 1
HbA1c (%, mean  SD) 7
Diabetic retinopathy (No.) 47/
Duration of disease (y, mean  SD) 8
*P  .05 versus patients with diabetes without insulin therapy.
†P  .01 versus patients with diabetes without insulin therapy.icantly between those receiving insulin and those not re-
The Journal of Thoraciceiving insulin (Table 3). At 6 months, there was a signif-
icant difference in incidence of cognitive decline between
patients with diabetes with insulin therapy (41/78; 80%) and
patients with diabetes without insulin therapy (10/102,
9.8%, P  .001; Table 3), and there were significant dif-
ferences in HbA1c, fasting blood sugar, and incidence of
diabetic retinopathy between those receiving insulin and
ys and 6 months, after the operation in the two groups
7 d 6 mo
43.0  3.4 44.9  2.8
43.0  2.8 45.9  2.6
58.4  11.1*† 51.1  6.0*†
53.7  9.1 47.5  6.0
192.9 38.2* 170.0  23.2
183.4 42.4* 169.0  28.1
10.5 3.2 9.7  2.6
10.7 3.6 10.7  3.0
27.1  4.9*† 23.4  2.0
24.0  4.7* 23.1  3.0
46.2  4.3*† 45.0  7.0*†
44.0  2.7* 42.0  5.0
29.4  3.0* 25.3  2.4
27.3  3.2* 24.9  3.8
from the Rey Auditory Verbal Learning Test.
ve impairment with and without insulin therapy at 7 days
ulin Without insulin P value
9%) 68/102 (67%) .001
33 132 24
1.8 6.1  1.7
%)* 11/102 (4%) .001
5.0 7.5  4.5
%)† 10/102 (9.8%) .001
30 122 22
0.9 5.2  1.2
%)† 4/102 (4%) .001
5.5 6.5  4.27 da
2
9
rivedgniti
th ins
/78 (6
43
.8 
78 (60
.0
78 (80
48
.2 
78 (60
.7those not receiving insulin (Table 3).
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tes with postoperative cognitive dysfunction and patients
with no postoperative cognitive dysfunction at 7 days and 6
months. Presence of hypertension (P  .01), SvO2 less than
50% time (P  .02), presence of ascending aorta athero-
TABLE 4. Characteristics of patients with type 2 diabetes w
7 d
No.
Age (y, mean  SD)
Weight (kg, mean  SD)
Height (cm, mean  SD)
Hypertension (No.)
Smoking (No.)
Female (%)
Preoperative left ventricular ejection fraction (%, mean  SD)
Hemoglobin (g/dL, mean  SD)
CPB time (min, mean  SD)
Integrated area under mean arterial pressure curve (mean  S
PaCO2 (mm Hg, mean  SD)
SvO2 less than 50% time (min, mean  SD)
Change in tympanic temperature (°C, mean  SD)
Ascending aorta atherosclerosis (No.)
Carotid artery stenosis (No.)
Diabetic retinopathy (No.)
HbA1c (%, mean  SD)
Duration of disease (y, mean  SD)
Fasting blood sugar (mg/dL, mean  SD)
Peak perioperative glucose level (mg/dL, mean  SD)
6 mo
No.
Age (y, mean  SD)
Weight (kg, mean  SD)
Height (cm, mean  SD)
Hypertension (No.)
Smoking (No.)
Female (%, mean  SD)
Preoperative left ventricular ejection fraction (%, mean  SD)
Hemoglobin (g/dL, mean  SD)
CPB time (min, mean  SD)
Integrated area under mean arterial pressure curve (mean  S
PaCO2 (mm Hg, mean  SD)
SvO2 less than 50% time (min, mean  SD)
Change in tympanic temperature (°C, mean  SD)
Ascending aorta atherosclerosis (No.)
Carotid artery stenosis (No.)
Diabetic retinopathy (No.)
HbA1c (%, mean  SD)
Duration of disease (y, mean  SD)
Fasting blood sugar (mg/dL, mean  SD)
Peak perioperative glucose level (mg/dL, mean  SD)
Unpaired t test or 2 test was used for the comparison between groups.sclerosis (P  .01), and diabetic retinopathy (P  .049)
580 The Journal of Thoracic and Cardiovascular Surgery ● Mardiffered significantly between patients with and without
postoperative cognitive dysfunction at 7 days after the op-
eration (Table 4). Diabetic retinopathy (P  .001), HbA1c
(P  .001), and fasting blood sugar (P  .04) differed
significantly between patients with and without postopera-
nd without cognitive dysfunction at 7 days and at 6 months
No cognitive
dysfunction
Cognitive
dysfunction P value
58 122
62 8 69  10 .09
60 11 66  12 .19
159 10 163  7 .28
30/58 (52%) 106/122 (87%) .01
29/58 (50%) 62/122 (51%) .99
23% 25% .36
57 9 54  12 .29
12.7 1.0 12.4 1.2 .51
109 20 116  22 .66
120 19 127  29 .26
36  5 37  5 .78
20.1 9.4 46.2 7.2 .02
1.1 0.6 1.4  0.9 .19
10/58 (17%) 43122 (35%) .01
5/58 (8.6%) 15/122 (12.3%) .45
11/58 (19%) 40/122 (33%) .049
6.1  1.2 6.6  1.2 .11
6.3  2.8 6.6  4.3 .25
129 16 137  23 .34
199 37 233  48 .14
129 51
63 11 64  10 .11
62 10 65  13 .30
159 10 160  9 .68
98/129 (76%) 38/51 (75%) .96
63/129 (49%) 28/51 (55%) .46
20% 27% .29
59 9 57  11 .33
12.3 1.1 12.7 0.9 .21
106 22 114  22 .56
122 22 133  31 .46
35  4 37  3 .38
24.0 4.4 26.6 8.9 .29
1.1 0.5 1.0  0.6 .39
33/129 (26%) 20/51 (39%) .075
13/129 (10%) 7/51 (14%) .49
12/129 (9%) 39/51 (76%) .001
5.1  0.8 6.9  1.0 .001
5.3 2.6 7.6  4.6 .09
113 18 137  33 .04
192 33 231  49 .09ith a
D)
D)tive cognitive dysfunction at 6 months after the operation
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P(Table 4). At 7 postoperative days, cognitive impairment
was associated with age (OR 1.5, 95% CI 1.3-1.8, P  .03),
presence of hypertension (OR 1.8, 95% CI 1.3-2.0, P 
.01), SvO2 less than 50% time (OR 1.5, 95% CI 1.1-2.0, P
 .045), presence of ascending aorta atherosclerosis (OR
1.5, 95% CI 1.1-2.6, P .01), diabetic retinopathy (OR 2.0,
95% CI 1.3-3.0, P .01), and insulin therapy (OR 2.0, 95%
CI 1.3-3.0, P  .05; Table 5). At 6 postoperative months,
cognitive impairment was associated with insulin therapy
(OR 2.0, 95% CI 1.3-3.8, P  .01), diabetic retinopathy
(OR 2.1, 95% CI 1.2-2.7, P  .01), and HbA1c (OR 1.9,
95% CI 1.3-3.1, P  .047; Table 5). Insulin therapy (OR
2.1, 95% CI 1.4-3.5, P .01), diabetic retinopathy (OR 2.4,
95% CI 1.4-2.9, P  .01), and HbA1c (OR 2.0, 95% CI
1.5-3.3, P  .042) were associated with postoperative cog-
nitive impairment (Table 5).
Discussion
The principal findings of this study are as follows: (1)
Cognitive dysfunctions was more evident and frequent
among patients with type 2 diabetes than in patients without
diabetes at 7 days and at 6 months after CABG. (2) Hyper-
tension, reduced SvO2, and ascending aorta atherosclerosis
were associated with short-term cognitive dysfunction in
patients with type 2 diabetes, whereas, insulin therapy,
diabetic retinopathy, and HbA1c were associated with cog-
nitive impairment at 6 months after CABG among patients
with type 2 diabetes.
Many studies have found that diabetes mellitus is asso-
ciated with a worse long-term outcome after CABG.1,8,11
Newman and associates11 reported that diabetes was one of
the key variables predicting major perioperative neurologic
events. Hogue and colleagues8 showed that diabetes was an
independent predictor of delayed stroke. These reports led
us to examine the mechanisms associated with postopera-
tive adverse neurologic events in patients with diabetes.
One possible cause of postoperative cognitive dysfunc-
tion in patients with diabetes mellitus is impaired cerebro-
vascular circulatory and vasodilatory reserves.12-14 Crough-
well and colleagues12 reported that the cerebral blood flow
(CBF) of their diabetic group was constant despite an in-
crease in temperature from 27°C to 37°C, in contrast to an
83% increase in CBF in the control group. They concluded
that patients with type 2 diabetes receiving insulin had
impaired CBF autoregulation. In a series of studies,13,14 we
found that patients with diabetes had a reduced cerebral
oxygenation, as estimated by SvO2, during CPB, and that
reduced SvO2 during CPB was associated with cognitive
dysfunction in elderly patients.7 There is controversy re-
garding the results of studies of cerebrovascular carbon
dioxide reactivity in patients with diabetes. Dandona and
associates15 examined the reactivity of CBF, challenging
with 5% carbon dioxide in 59 patients with diabetes, and
The Journal of Thoracifound that patients with diabetes had diminished cerebro-
vascular reserve. In contrast, Kawata and coworkers16 re-
ported that the relative values of carbon dioxide reactivity in
patients with diabetes were equivalent to those of the con-
trol group during isoflurane anesthesia. In an animal study
by Sieber and colleagues,17 4 months of hyperglycemia
increased CBF and cerebral metabolic rate for oxygen. They
speculated that the effects of diabetes mellitus on the cere-
bral vasculature were complicated by a host of factors,
including diabetic microangiopathy, atherosclerosis, hyper-
tension, renal disease, and chronic hyperglycemia, and con-
cluded that it was likely that many of the reported abnor-
malities in CBF physiology were the results of diabetic
vascular disease, rather than an effect of hyperglycemia.
This study is the first to show that insulin therapy,
HbA1c, and retinopathy are associated with cognitive im-
pairment at 6 months after CABG. Although we cannot
explain why these factors are related to cognitive impair-
ment, prolonged hyperglycemia may be a factor. Pallas and
associates18 noted that hyperglycemia leads to impaired
vascular function though changes in endothelial cell func-
tion. The pathway that appears most affected by the diabetic
state is that of nitric oxide. Loss of this pathway is accom-
panied by loss of response to PaCO2 and lack of autoregu-
lation related to flow-pressure relationships. The United
Kingdom Prospective Diabetes Study19 reported that inten-
sive blood glucose control substantially decreases the risk of
microvascular complications. Our results indicate that high
HbAc1 and diabetic retinopathy reflect poorly controlled
diabetes, suggesting that severity of microangiopathy in
patients with diabetes with high HbA1c is higher than that in
patients with diabetes with normal HbA1c.20 Ono and col-
TABLE 5. Independent predictors of cognitive impairment
at 7 days or 6 months after cardiac surgery in patients with
type 2 diabetes
Variables OR 95% CI P value
All cognitive impairment
HbA1c (%) 2.0 1.5-3.3 .042
Diabetic retinopathy 2.4 1.4-2.9 .01
Insulin therapy 2.1 1.4-3.5 .01
Short-term cognitive impairment
Age 1.5 1.3-1.8 .03
Hypertension 1.8 1.3-2.0 .01
Svo2 less than 50% time 1.5 1.1-2.0 .045
Ascending aorta atherosclerosis 1.5 1.1-2.6 .01
Diabetic retinopathy 2.0 1.3-3.0 .01
Insulin therapy 2.0 1.3-3.0 .05
Long-term cognitive impairment
HbA1c (%) 1.9 1.3-3.1 .047
Diabetic retinopathy 2.1 1.2-2.7 .01
Insulin therapy 2.0 1.3-3.8 .01leagues21 reported that retinal circulation may be an indi-
c and Cardiovascular Surgery ● Volume 129, Number 3 581
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velops from the forebrain. In a previous study,22 we
reported that cerebral vasodilatory response to hypercapnia
was impaired in patients with diabetes with retinopathy
relative to patients with diabetes without retinopathy and
found that HbA1c was positively related to impaired cere-
brovascular carbon dioxide reactivity. Stratton and associ-
ates23 reported that in patients with type 2 diabetes the risk
of diabetic complications, such as macrovascular and mi-
crovascular disease, was strongly associated with previous
hyperglycemia. This implies that the primary cause of mi-
crovascular disease is chronic hyperglycemia itself and that
poorly controlled blood sugar induces disturbed cerebrovas-
cular microcirculation, which may have adverse effects on
postoperative cognitive function. Among our 51 patients
with diabetes with cognitive impairment 6 months after the
operation, those who received insulin therapy had a disease
duration of almost 9 years, whereas those who did not
receive insulin therapy had a disease duration of 6.5 years.
Type 2 diabetes may be present for prolonged periods
before diagnosis, and as many as 50% of patients may have
significant disorders, such as diabetic microvascular com-
plications, without clinical symptoms before the disease is
diagnosed.24 Elevated HbA1c and diabetic retinopathy are
indicators of poor control of diabetes and are also indicators
of the duration of type 2 diabetes, because most patients
with type 2 diabetes have the condition diagnosed several
years after onset.
The Diabetes Mellitus Insulin Glucose Infusion in Acute
Myocardial Infarction study19 demonstrated that tight glu-
cose control reduces risk of mortality. Moreover, Ohkubo
and coworkers25 reported that intensive blood glucose ther-
apy prevented progression of diabetic microvascular com-
plications in Japanese patients with non–insulin-dependent
type 2 diabetes mellitus. Our results indicate that intensive
preoperative blood glucose therapy may be important for
reduction of the incidence of postoperative cognitive im-
pairment.
Study Limitations
We did not identify any relationship between postoperative
cognitive dysfunction and ascending aorta atherosclerosis or
carotid artery stenosis at 6 months after surgery. Several
reports have shown that ascending aorta atherosclerosis and
carotid artery stenosis represent major factors associated
with cognitive dysfunction.1,11 The incidence of ascending
aorta atherosclerosis or carotid artery stenosis among our
patients may have been too small to detect a relationship. In
addition, there is controversy regarding the definition of a
significant level of narrowing.8,26,27 The North American
Symptomatic Carotid Endarterectomy Trial26 report defined
carotid artery stenosis as narrowing greater than 70%. In
contrast, White and coworkers27 defined carotid artery ste-
582 The Journal of Thoracic and Cardiovascular Surgery ● Marnosis as narrowing greater than 60%. Further study is
needed to determine the relationship between postoperative
cognitive dysfunction and ascending aorta atherosclerosis or
carotid artery stenosis.
Because we selected normothermic CPB, we strictly
controlled tympanic temperature during the CPB period in
this study. Hypothermia is known to protect against brain
ischemia, and hyperthermia is known to be a risk factor of
postoperative cognitive dysfunction.28 We cannot rule out
the possibility that different results would be obtained for
hypothermic CPB.
In this study we excluded patients with major neurologic
outcome and incomplete data from cognitive function anal-
ysis. This may have had some effects on our results. Ras-
mussen and associates29 recommended in a review article
that tests with missing data not be used for evaluation of
cognitive function simply because such missing data can not
be substituted in any reasonable way.
We followed the recommendations for neuropsychologic
testing and the definition of postoperative cognitive dys-
function provided in the consensus statements on the as-
sessment of central nervous system disorders.10 The test
used in this study is widely accepted for evaluation of
postoperative cognitive function. There have been many
problems regarding definitions of postoperative cognitive
dysfunction. Rasmussen and associates29 reported in a re-
view of the literature that postoperative cognitive function
has been extensively researched but is a difficult matter to
evaluate. In addition, they found large differences in meth-
odology between studies, including test batteries, interval
between sessions, the end points analyzed, statistical meth-
ods, and definitions of neuropsychologic defects and post-
operative cognitive dysfunction.
Our study provided 80% power to detect a 20% differ-
ence between patients with diabetes with insulin therapy
and patients with diabetes without insulin therapy, with a
5% probability of type I error. Determining the significance
of a 10% difference between two groups would have re-
quired a total sample size of 297,654.
Conclusion
In this study, there were no differences in peak perioperative
glucose level between the diabetes and control groups or
between patients with and without cognitive dysfunction.
Insulin therapy, diabetic retinopathy, and HbA1c were asso-
ciated with cognitive impairment 6 months after CABG.
Recent studies24,30 indicate that aggressive glucose control
in both patients with and without diabetes can improve
survival without excessive consequences related to hypo-
glycemia. This suggests that maintaining the “tight” glyce-
mic control reported by Van Den Berghe and colleagues30
(maintaining blood glucose in the range of 80-110 mg/dL)
during the perioperative period can improve postoperative
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Pcognitive function in patients undergoing cardiac surgery.
Further study should help to clarify the optimal blood glu-
cose concentration and the role of maintaining euglycemia
in patients undergoing cardiac surgery.
We thank Forte Inc, Tokyo, Japan, for assistance with the
manuscript.
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